Armistice Capital, Other Investors Grow Their Stake in Medical Product Providers
Stock from businesses that produce treatments and other health care-related items has drawn interest from institutional investors in recent months — including shares of biopharmaceutical company Alkermes. The Massachusetts-based company, which distributes its products globally, has created items that address a variety of complex psychiatric and neurological conditions, ranging from schizophrenia to alcohol and opioid…

